Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes
Open accessThe DOI matches its Crossref record; 50 of the 55 references it cites were found in a registry or an index; 6 of the 54 sources its claims cite were checked for support.
Abstract
Introduction People who use methamphetamine (MA) regularly, often experience symptoms of mental ill health associated with the use of the drug. These include symptoms of psychosis, depression, anxiety and also cognitive deficits. Accordingly, psychological treatments aim to reduce MA use and related problems, including symptoms of mental ill health. Although there has been a substantial body of research reporting on the evidence of effectiveness of psychological treatments for MA use, there is a paucity of research addressing the effectiveness of these treatments for coexisting symptoms of mental ill health. We aim to address this gap by providing a comprehensive overview of the evidence for psychological treatments for MA use and associated symptoms of mental ill health in experimental/controlled clinical studies. In addition, a critical evaluation of study methods and the outcomes of psychological interventions on MA use and symptoms of mental ill health will be conducted. Methods and analysis The Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement will be used to inform the methods of this review. Eight electronic peer-reviewed databases will be searched. Pilot searches have been conducted for MA literature considering controlled clinical trials only. Eligible articles will be independently assessed against inclusion criteria. Before final analyses are completed, searches will be rerun and if eligible, additional studies will be retrieved for inclusion. A quantitative synthesis of the findings will be reported where possible, and 'summary of findings' tables will be generated for each comparison. Risk ratios and 95% CI (dichotomous outcomes) will be calculated and/or effect size according to Cohen's formula (continuous outcomes) for the primary outcome of each trial. Ethics and dissemination No ethical issues are foreseen. Findings will be disseminated widely to clinicians and researchers via journal publication and conference presentation(s). Trial registration number CRD42016043657. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Overview
CoChat Summary
## TL;DR
This is a protocol for a systematic review, not the review’s results, so it outlines how the authors will assess psychological treatments for methamphetamine (MA) use and co-occurring mental health outcomes. The planned review will synthesize controlled clinical studies in adults using MA and examine MA use, abstinence, and mental health symptoms or disorders.
## Key findings
- Not stated in the paper.
- The authors state this will be “the first systematic review of interventions for methamphetamine (MA) use and associated mental health outcomes.”
- The review will include controlled trials where studies report both MA use and mental health symptoms/disorders at baseline and post-treatment.
- The protocol specifies planned effect measures: risk ratios with 95% CIs for dichotomous outcomes and Cohen’s d for continuous outcomes; if sample sizes are small, Hedge’s g will be used instead.
## Methods
- Systematic review protocol informed by the Cochrane Handbook for Systematic Reviews of Interventions and PRISMA guidelines.
- Planned search of eight electronic databases plus registration databases; eligible studies are controlled clinical trials, including RCTs (cluster and parallel design), with adults over 18 using MA alone or with other substances.
- Planned synthesis includes meta-analysis “if possible,” otherwise narrative synthesis; study quality will be assessed with the Cochrane Risk of Bias tool and overall certainty with GRADE.
## Limitations
- The paper itself notes that most trials have been conducted in Western countries, so generalisability to other contexts is unknown.
- The authors note that if a meta-analysis is appropriate, it assumes interventions are methodologically consistent across studies.
- Evident from the text: this is a protocol, so it reports intended methods rather than actual review findings or effect estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 37 Not checked · 16 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In a review conducted by Elkashef et al,25 pharmacotherapies such as bupropion and sertraline did not increase abstinence from MA in groups who received this drug compared with controls.26”
§ Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes > Introduction > Rationale
What the sources say
- Not checked — no full text of the sourcecites [25] matched to “Bupropion for the treatment of methamphetamine dependence” (2008) source
- Partly supportedcites [26] Anderson, 2015, Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial, Drug Alcohol Depend sourceExperimental — accuracy not yet measured
The Abstract Results and Discussion report that bupropion did not significantly increase methamphetamine abstinence compared with placebo in this trial of less-than-daily users. The paper is a bupropion trial, not a review by Elkashef et al., and the searched passages do not support the claim about sertraline. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These interventions have also been associated with positive mental health outcomes, such as improved well-being, following treatment in people who use MA.34”
§ Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes > Introduction > Rationale
What the sources say
- Partly supportedcites [34] matched to “Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial” (2006) sourceExperimental — accuracy not yet measured
The Results report short-term improvement in depression and improved general functioning after motivational interviewing/CBT. However, these mental-health outcomes are reported for participants with psychotic disorders and substance use generally, not specifically for those who use methamphetamine; the paper discusses amphetamine users separately in relation to substance use. Page numbers are unavailable in our copy. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
In the paper
“The shift to crystal MA use in Australia has seen mental health problems associated with this form of the drug substantially worsen.”
§ Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes > Introduction > Rationale
What the sources say
- Not matchedcites [13] NSW Health. Crystalline methamphetamine. background paper. 2015. NSW Government (accessed 20 Aug 2015).
We searched by its title and found no matching paper.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“From 2009 to 2014, the annual total number of mental health presentations, overdose and drug and alcohol presentations at NSW public hospital emergency departments related to MA use increased more than sevenfold, from 394 to 296.13”
§ Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes > Introduction > Rationale
What the sources say
- Not matchedcites [13] NSW Health. Crystalline methamphetamine. background paper. 2015. NSW Government (accessed 20 Aug 2015).
We searched by its title and found no matching paper.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Psychostimulants are a unique group of substances because they are more likely to induce psychosis than other illicit drugs.14”
§ Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes > Introduction > Rationale
What the sources say
- Not checked — no full text of the sourcecites [14] matched to “Major physical and psychological harms of methamphetamine use” (2008) source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
18 more claims
Create a free account to see all 59 claims and every source verdict.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 21
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Knapp WPS, Farrell, M B, Silva de Lima M Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders (Review). Cochrane Database Syst Rev 2007; 18: CD003023. 17636713”
Cited work 10.1002/14651858.cd003023.pub2 · retracted 2015-04-02 · notice 10.1002/14651858.cd003023.pub3 · this paper published 2017-09
Citations
Cites
1 retracted
Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders
Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003023.pub2 · Cited by 178
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303 · cited 1×
“The disease burden in Australia attributable to MA is of international relevance as Australia has reputable data for mortality rates, and the rates of illicit drug use are similar to those in other high-income countries.(11) In recent years, a more potent form of MA (crystal) has increased in popularity across the glo…”
ResultEvidence for physiotherapy practice: A survey of the Physiotherapy Evidence Database (PEDro)
Moseley, A. M., Herbert, R. D., Sherrington, C., & Maher, C. G. (2002) · Australian Journal of Physiotherapy · doi:10.1016/s0004-9514(14)60281-6 · Cited by 911 · cited 1×
“If disagreement occurs, final ratings will be made via consensus, following discussion with coauthors.(46) The ‘Cochrane Collaboration’s Risk of Bias’ tool will be used to measure risk of bias(45) with items judged as low, high or unclear risk.”
MethodMajor physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675 · cited 2×
“Although vulnerability to psychotic symptoms differs among people who use MA, these symptoms are more apparent in people who use MA on a regular basis.(14) In addition, depression, anxiety, suicidal ideation, dysphoria and cognitive deficits have been commonly reported to co-occur in people using MA.”
Background
Research works printed but not linked: 2
- Shoptaw, 2009, Treatment for amphetamine withdrawal, Cochrane Database Syst Rev, 2
- Boissel, 1999, Methodology outline of the problem of indices of therapeutic efficacy. II the Indices, Therapie, 54, 309
Cited by
Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options
Chiang, M., Lombardi, D., Du, J., Makrum, U., Sitthichai, R., Harrington, A., Shukair, N., Zhao, M., & Fan, X. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2710 · Cited by 71
Stuart, A. M., Baker, A. L., Denham, A. M. J., Lee, N. K., Hall, A., Oldmeadow, C., Dunlop, A., Bowman, J., & McCarter, K. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.09.005 · Cited by 49
Self-citationO'Donnell, A. J., Addison, M. T., Spencer, L. P., Zurhold, H., Rosenkranz, M., McGovern, R., Gilvarry, E. A., Martens, M., Verthein, U., & Kaner, E. (2018) · Addiction · doi:10.1111/add.14434 · Cited by 55
“Epidemiological evidence also confirms that psychostimulants are more likely to induce psychosis than other illicit substances [81], with depression, anxiety and suicidal ideation commonly co-occurring among methamphetamine users [82].”
BackgroundMidlife and Older Age Methamphetamine Poisoning Deaths in Hawai‘i
Sidhu, G. K., Fontanilla, T. M., & Becker, T. S. (2024) · Hawai‘i Journal of Health & Social Welfare · doi:10.62547/wwzl3153 · Cited by 2
Psychosocial treatment for methamphetamine use and the associated mental health symptoms
Mann, A., & Wagstaff, C. (2019) · Advances in Dual Diagnosis · doi:10.1108/add-11-2018-0022
Metadata
- Authors
- Stuart, A., Baker, A. L., Bowman, J., McCarter, K., Denham, A. M. J., Lee, N., Colyvas, K., & Dunlop, A.
- Affiliations
- University of Newcastle Australia (AU)
- Curtin University (AU)
- Corresponding author
- Stuart, Alexandra
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-09
- Volume
- 7
- Issue
- 9
- Pages
- e015383
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC5595199
- OpenAlex
- W2753891124
- Cited by
- 7
- References
- 55
- Citations by year
- 2026: 1 · 2024: 1 · 2021: 1 · 2019: 3 · 2018: 1
- FWCI
- 0.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (acceptedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- methamphetamine use, psychological intervention, psychiatric symptoms, psychosis, depression, anxiety, cognitive impairment, substance use disorders, treatment effectiveness, co-occurring mental illness
- MeSH terms
- Systematic Reviews as Topic, Mental Disorders, Humans, Mental Health, Methamphetamine, Psychotherapy, Research Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes. https://app.cochat.ai/papers/10.1136/bmjopen-2016-015383
- The paper
- Stuart, A., Baker, A. L., Bowman, J., McCarter, K., Denham, A. M. J., Lee, N., Colyvas, K., & Dunlop, A. (2017). Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes. BMJ Open. https://doi.org/10.1136/bmjopen-2016-015383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.